Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Certara Inc (NQ: CERT )

9.770 +0.220 (+2.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,265,465
Open 9.580
Bid (Size) 9.400 (10)
Ask (Size) 10.01 (2)
Prev. Close 9.550
Today's Range 9.410 - 9.800
52wk Range 9.410 - 19.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Forecasting The Future: 4 Analyst Projections For Certara
Via Benzinga
Certara Reports Third Quarter 2024 Financial Results
Updates Full Year 2024 Financial Guidance 
From Certara
Via GlobeNewswire

Performance

YTD
-43.69%
-43.69%
1 Month
-12.77%
-12.77%
3 Month
-24.26%
-24.26%
6 Month
-42.26%
-42.26%
1 Year
-32.25%
-32.25%

More News

Read More
Certara to Participate in the Stephens Annual Investment Conference
From Certara
Via GlobeNewswire
Certara Appoints John Reynders as New Independent Board Member
From Certara
Via GlobeNewswire
Beyond The Numbers: 4 Analysts Discuss Certara Stock
Via Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
Via Benzinga
MaxCyte Appoints Cynthia Collins to its Board of Directors
From MaxCyte, Inc
Via GlobeNewswire
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
From Certara
Via GlobeNewswire
Certara Completes Acquisition of Chemaxon
From Certara
Via GlobeNewswire
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Certara’s Simcyp Consortium Celebrates 25th Anniversary
From Certara
Via GlobeNewswire
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
From Certara
Via GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software
From Certara
Via GlobeNewswire
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Certara Reports Second Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
From Certara
Via GlobeNewswire
Simulations Plus Stock Drops 15% Despite EPS Beat
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
From Certara
Via GlobeNewswire
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
From Certara
Via GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Certara Appoints New Chief Human Resources Officer & General Counsel
From Certara
Via GlobeNewswire
CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Certara Reports First Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.